InvestorsHub Logo

BioTechMaven

05/23/17 8:16 PM

#183088 RE: Spebenz #183085

What's funny is the relative nature of price entries. Those who bought in the .60s over the last month got what I believe is the deal of the century. But, deals of the century now are whatever the current price is, all the way up to what I feel is a fair valuation of $800m-$1b pre release. I believe the end result of CTIX will be at a minimum of $20/share and a maximum of $150/share, and that only now with four big trials giving results this year will see just where we land. So, in relative terms, and if you believe the valuation and potential, buying at $10-$15, would even deliver value proposition that most struggle to achieve in a given year.